Novel difunctional aromatic synthons consisting of iV-(2-carbomethoxyphenyl) imidate esters were synthesized by treatment of methyl anthranilate esters with aliphatic ortho esters. Treatment of the imidates with hydrazine, methylhydrazine, and phenylhydrazine yielded only quinazolinones and not isomeric l,3,4-benzotriazepin-5-ones.The type of products obtained gave information relevant to elucidation of the mechanism of cyclization and the relative reactivities of the ester and imidate groups.
Treatment of substituted 2‐aminobenzoyl hydrazides with orthoesters has been found to yield different products depending upon the type of orthoester employed. Equimolar quantities of orthoester and hydrazide yield 3‐amino‐4(3H)‐quinazolinones, whereas utilization of a two‐fold excess (or greater) of orthoester yields, in some cases, 3,4‐dihydro‐5H‐1,3,4‐benzotriazepin‐5‐ones as minor products in addition to N‐[4(3H)‐quinaz‐olinon‐3‐yl]imidate esters as major products. Treatment of hydrazides with trimethyl orthobenzoate yields substituted 5‐(2‐aminophenyl)‐1,3,4‐oxadiazoles and 3,4‐dihydro‐5H‐1,3,4‐benzotriazepin‐5‐ones. The steric bulk of the phenyl group in trimethyl orthobenzoate effects the formation of adduct at the β‐nitrogen of the hydrazide which cyclized to the oxadiazole and benzotriazepinone products. In the aliphatic orthoester series, the formation of adduct to the aromatic amino group appears to be favored which gives rise to quinazolinone and benzotriazepinone products.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.